uracil has been researched along with Anticipatory Vomiting in 7 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
Excerpt | Relevance | Reference |
---|---|---|
"We performed a controlled study to compare the response to cyclophosphamide (CPA), adriamycin (ADM), and fluorouracil (5-FU) (CAF therapy) with that to uracil-tegafur (UFT) plus tamoxifen (TAM) (UFT+TAM therapy), when given as postoperative adjuvant therapy to women with breast cancer." | 9.12 | [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set ( Inaji, H; Koyama, H; Mori, T; Nakao, K; Oka, T; Oshima, A; Ozawa, K; Saito, Y; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T, 2006) |
"We performed a controlled study to compare the response to cyclophosphamide (CPA), adriamycin (ADM), and fluorouracil (5-FU) (CAF therapy) with that to uracil-tegafur (UFT) plus tamoxifen (TAM) (UFT+TAM therapy), when given as postoperative adjuvant therapy to women with breast cancer." | 5.12 | [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set ( Inaji, H; Koyama, H; Mori, T; Nakao, K; Oka, T; Oshima, A; Ozawa, K; Saito, Y; Sakai, K; Senoo, T; Taguchi, T; Terasawa, T, 2006) |
"Concomitant treatment with 5-fluorouracil (5-FU) and Leucovorin (LV) is positioned as the standard chemotherapy against colorectal cancer." | 3.72 | [Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer]. ( Anazawa, S; Hirai, K; Kawahara, H; Ogawa, M; Sakuyama, T; Sato, K; Takao, Y; Yamazaki, Y; Yokoyama, M, 2004) |
"Uracil-tegafur (UFT) has been reported to have broad antitumor activity in a variety of malignancies." | 2.71 | A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma. ( Furuse, J; Ikeda, M; Ishii, H; Morizane, C; Okusaka, T; Ueno, H, 2005) |
"Tegafur is a prodrug that is converted to 5-fluorouracil (5-FU) and has been reported to be less toxic and to have a higher therapeutic index." | 1.31 | Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience. ( Chen, PM; Chiou, TJ; Fan, FS; Hsieh, RK; Hsu, TC; Jiang, JK; Lin, JK; Lin, TC; Liu, JH; Wang, HS; Wang, WS; Yang, SH; Yen, CC, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakuyama, T | 1 |
Yokoyama, M | 1 |
Ogawa, M | 1 |
Takao, Y | 1 |
Sato, K | 1 |
Kawahara, H | 1 |
Anazawa, S | 1 |
Yamazaki, Y | 1 |
Hirai, K | 1 |
Ikeda, M | 1 |
Okusaka, T | 1 |
Ueno, H | 1 |
Morizane, C | 1 |
Furuse, J | 1 |
Ishii, H | 1 |
Ito, T | 1 |
Hata, Y | 1 |
Matsuoka, S | 1 |
Nakajima, N | 1 |
Yokoyama, R | 1 |
Honda, S | 1 |
Sano, F | 1 |
Akasaka, Y | 1 |
Ohmori, K | 1 |
Ishida, H | 1 |
Akita, H | 1 |
Watanabe, Y | 1 |
Nakaguchi, K | 1 |
Kabuto, T | 1 |
Sato, Y | 1 |
Inaba, Y | 1 |
Yamaura, H | 1 |
Shimamoto, H | 1 |
Nishiofuku, H | 1 |
Oyama, T | 1 |
Kanemitsu, Y | 1 |
Sawaki, A | 1 |
Arai, Y | 1 |
Muro, K | 1 |
Inaji, H | 1 |
Sakai, K | 1 |
Oka, T | 1 |
Ozawa, K | 1 |
Saito, Y | 1 |
Senoo, T | 1 |
Taguchi, T | 1 |
Terasawa, T | 1 |
Nakao, K | 1 |
Mori, T | 1 |
Koyama, H | 1 |
Oshima, A | 1 |
Lin, JK | 1 |
Wang, WS | 1 |
Hsieh, RK | 1 |
Hsu, TC | 1 |
Chiou, TJ | 1 |
Liu, JH | 1 |
Fan, FS | 1 |
Yen, CC | 1 |
Lin, TC | 1 |
Jiang, JK | 1 |
Yang, SH | 1 |
Wang, HS | 1 |
Chen, PM | 1 |
3 trials available for uracil and Anticipatory Vomiting
Article | Year |
---|---|
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Biliary Tract Neoplasms; Drug Adm | 2005 |
[Clinical evaluation of chemotherapy with irinotecan (CPT-11), l-leucovorin (l-LV), 5-fluorouracil (5-FU), and UFT for metastatic or recurrent colorectal cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug A | 2005 |
[A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant set
Topics: Anorexia; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Ne | 2006 |
4 other studies available for uracil and Anticipatory Vomiting
Article | Year |
---|---|
[Home chemotherapy by concomitant UFT + Leucovorin (po.) in postoperative colorectal cancer patients assessed with Dukes D and curability C colorectal cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Diarrhea; Drug Administration | 2004 |
[Complete response to CPT-11 and UFT/LV combination therapy in a case with simultaneous multiple lung metastases from colon cancer].
Topics: Adenocarcinoma; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neop | 2006 |
[Retrospective analysis of tegafur/uracil (UFT) plus oral leucovorin (LV) regimen in patients with advanced colorectal cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 2006 |
Phase II study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C | 2000 |